Nuclear Medicine/ Radiopharmaceuticals Market By Type (Diagnostics Radiopharmaceuticals, PET Radiopharmaceuticals), By Application (Therapeutic, Diagnostic Application) - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

Nuclear medicine/ radiopharmaceuticals are agents used to diagnose certain medical problems or treat certain diseases condition. Increasing awareness of radiopharmaceuticals, growing number of pharmaceutical companies and rising research institutes are major factors that assisting the growth of nuclear medicine/ radiopharmaceuticals market globally.

The report titled “Nuclear medicine/ radiopharmaceuticals Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall radiopharmaceuticals market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on type (diagnostic and therapeutic radiopharmaceuticals), application (diagnostics, diagnostic applications) and different geographical regions. Geographically, the global nuclear medicine/ radiopharmaceuticals market is studied for the following regional markets:    

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East and Africa
    • GCC
    • Rest of MEA

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global nuclear medicine/ radiopharmaceuticals market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global nuclear medicine/ radiopharmaceuticals market. This report concludes with company profiles section that highlights major information about the key players engaged in global nuclear medicine/ radiopharmaceuticals market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report.      

Thus, the research study provides a holistic view of the global radiopharmaceuticals market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Nuclear Medicine/ Radiopharmaceuticals Market

Based on application, the global nuclear medicine/ radiopharmaceuticals market is segmented as follows:

  • Therapeutic
    • Thyroid
    • Oncology
    • Bone Metastasis
    • Other Applications
  • Diagnostics
    • Cardiology
    • Thyroid
    • Oncology
    • Other Therapeutic Application

Radiopharmaceutical is a radioactive pharmaceutical agent that is used for diagnostic or therapeutic procedures, depending upon its physicochemical and radiation properties. Application of radiopharmaceuticals is categorized into two major areas, diagnostic and therapeutic. It is estimated that, therapeutic application will show fastest market growth during forecast period due to its advantages over the traditional drug therapies such as targeted therapeutic action and lower side effects. Radiopharmaceuticals application in cardiology and oncology is anticipated to grow significantly during forecast period due to its increasing applicability in diagnosis of the disease; furthermore growing prevalence of different forms of cancer and cardiovascular disease will fuel the market growth. However, stringent regulatory guidelines regarding manufacturing of radiopharmaceuticals may negatively impacting the market growth of radiopharmaceuticals.

Nuclear Medicine/ Radiopharmaceuticals Market

For the purpose of this study, the nuclear medicine/ radiopharmaceuticals market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Nuclear Medicine/ Radiopharmaceuticals Market

It is observed that in the base year 2016, North America was largest revenue contributor in global nuclear medicine/ radiopharmaceuticals market; the market growth is mainly driven by United States. Technological advancement, higher investment in R&D activities, presence of key manufacturer and presence of large number of research institutes are major factors that are driving the radiopharmaceuticals market in North America. However, Asia Pacific is expected to show lucrative growth during forecast period due to increasing partnership of key players with local manufacturer, growing incidence and mortality of severe diseases, growing number of geriatric population, and rapidly expanding pharmaceutical industries in this region. Emerging Asian countries such as China and India are expected to exhibit highest market growth due developing economic condition and growing partnership of key players with local manufacturers.

Choose License Type
Published Date:  Oct 2017
Category:  Pharmaceuticals
Report ID:   58722
Report Format:   PDF
Pages:   120
Rating:    4.1 (40)
Connect With Us
24/7 Research Support